Research Directory

A scenario for shortening drug development times

Read more

Big Pharma meets Big Data

Read more

Why the UK is building cell therapy capacity

Read more

Commentary: European IPOs produce surprises

Read more

European biotechs rise in March quarter

Read more

The case for allogeneic cell therapy

Read more

Clinical and market issues for cell-based therapies

Read more

Checkpoint inhibitors - A new horizon for cancer therapy

Read more

Will scanners be the key to translational medicine?

Read more

Why the time has come for MidPharmas

Read more